NCT03502980View on ClinicalTrials.gov

Safety and Efficacy of Midline and PICC

NACompletedINTERVENTIONAL
Enrollment

293

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

July 21, 2022

Study Completion Date

July 21, 2022

Conditions
Vascular Access DevicesCentral Venous Catheter
Interventions
DEVICE

Bard PowerPICC

PICC Insertion

DEVICE

Bard PowerMidline catheter

Midline Insertion

Trial Locations (1)

H2X 3E4

Centre hospitalier de l'université de Montréal, Montreal

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT03502980 - Safety and Efficacy of Midline and PICC | Biotech Hunter | Biotech Hunter